-
1
-
-
67651229051
-
Marginal medicine: Targeting comparative effectiveness research to reduce waste
-
Hoffman A, Pearson SD. Marginal medicine: targeting comparative effectiveness research to reduce waste. Health Aff 2009;28:710-8.
-
(2009)
Health Aff
, vol.28
, pp. 710-718
-
-
Hoffman, A.1
Pearson, S.D.2
-
2
-
-
77951041981
-
Complete lives in the balance
-
Kerstein SJ, Bognar G. Complete lives in the balance. Am J Bioeth 2010;10:37-45.
-
(2010)
Am J Bioeth
, vol.10
, pp. 37-45
-
-
Kerstein, S.J.1
Bognar, G.2
-
3
-
-
33745548740
-
Ethical issues in the use of cost effectiveness analysis for the prioritization of health care resources
-
Khushf G. Kluwer
-
Brock DW. Ethical issues in the use of cost effectiveness analysis for the prioritization of health care resources. In: Khushf G. Bioethics: a philosophical overview. Kluwer, 2004.
-
(2004)
Bioethics: A Philosophical Overview
-
-
Brock, D.W.1
-
4
-
-
84859003054
-
85% of new drugs "offer few benefits."
-
Aug 17
-
Von Radowitz J. 85% of new drugs "offer few benefits." Independent 2010 Aug 17. www.independent.co.uk/life-style/health-and-families/ health-news/85-of-new-drugs-offer-few-benefits-2054972.html.
-
(2010)
Independent
-
-
Von Radowitz, J.1
-
5
-
-
0038515640
-
Chemotherapy use among Medicare beneficiaries at the end of life
-
Emanuel EJ, Young-Xu Y, Levinsky NG, Gazelle G, Saynina O, Ash AS. Chemotherapy use among Medicare beneficiaries at the end of life. Ann Intern Med 2003;138:639-43.
-
(2003)
Ann Intern Med
, vol.138
, pp. 639-643
-
-
Emanuel, E.J.1
Young-Xu, Y.2
Levinsky, N.G.3
Gazelle, G.4
Saynina, O.5
Ash, A.S.6
-
6
-
-
18144406881
-
Futility: Clinical decisions at the end-of-life in women with ovarian cancer
-
DOI 10.1016/j.ygyno.2005.01.031
-
Von Gruenigen VE, Daly BJ. Futility: clinical decisions at the end-of-life in women with ovarian cancer. Gynecol Oncol 2005;97:638-44. (Pubitemid 40614915)
-
(2005)
Gynecologic Oncology
, vol.97
, Issue.2
, pp. 638-644
-
-
Von Gruenigen, V.E.1
Daly, B.J.2
-
7
-
-
84858997964
-
-
European Medicines Agency. Tarceva: EPAR summary for the public. 2010. www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000618/ human-med-001077.jsp&murl=menus/medicines/medicines.jsp&mid= WC0b01ac058001d124.
-
(2010)
Tarceva: EPAR Summary for the Public
-
-
-
8
-
-
66149185085
-
-
European Medicines Agency. Summary of product characteristics: Tarceva. 2010. www.ema.europa.eu/docs/en-GB/document-library/EPAR---Product-Information/ human/000618/WC500033994.pdf.
-
(2010)
Summary of Product Characteristics: Tarceva
-
-
-
10
-
-
70449523695
-
Marginale Wirksamkeit als Posteriorisierungskriterium- Begriffsklärungen und ethisch relevante Vorüberlegungen
-
Buyx AM, Friedrich DR, Schöne-Seifert B. Marginale Wirksamkeit als Posteriorisierungskriterium-Begriffsklärungen und ethisch relevante Vorüberlegungen. Eth Med 2009;21:89-100.
-
(2009)
Eth Med
, vol.21
, pp. 89-100
-
-
Buyx, A.M.1
Friedrich, D.R.2
Schöne-Seifert, B.3
-
11
-
-
0030928852
-
The rationing debate. Rationing health care by age
-
Evans JG. The rationing debate. Rationing health care by age. BMJ 1997;314:820-5.
-
(1997)
BMJ
, vol.314
, pp. 820-825
-
-
Evans, J.G.1
-
12
-
-
0017643601
-
You are dangerous to your health: The ideology and politics of victim blaming
-
Crawford R. You are dangerous to your health: the ideology and politics of victim blaming. Int J Health Serv 1977;4:663-80. (Pubitemid 8216143)
-
(1977)
International Journal of Health Services
, vol.7
, Issue.4
, pp. 663-680
-
-
Crawford, R.1
|